“Phoenixin-20 Protects Against Cellular Senescence in Rheumatoid Arthritis Fibroblast-like Synoviocytes by Downregulating STAT6”

https://pubmed.ncbi.nlm.nih.gov/38112587

The study found that the peptide Phoenixin-20 has protective effects against tumor necrosis factor α (TNF-α)-induced cellular senescence in rheumatoid arthritis fibroblast-like synoviocytes (FLS) by downregulating STAT6, suggesting its potential as a promising agent for rheumatoid arthritis treatment.